{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:55:04Z","timestamp":1785894904102,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012123","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000}}],"reference-count":56,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012123.pub2","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T07:11:05Z","timestamp":1607584265000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure"],"prefix":"10.1002","volume":"2020","author":[{"given":"Jacky TP","family":"Siu","sequence":"additional","affiliation":[{"name":"Lower Mainland Pharmacy Services; Fraser Health Authority; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Pharmacy; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky D","family":"Turgeon","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"10.1002\/14651858.CD012123.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD012123.pub2-BIB0002|cit2","first-page":"268A","article-title":"Intravenous N-acetylcysteine improves spontaneous survival in early stage non-acetaminophen acute liver failure","volume":"46","author":"Lee","year":"2007","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012123.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S897","DOI":"10.1016\/S0016-5085(11)63725-6","article-title":"A prospective clinical trial shows that intravenous N-acetylcysteine (NAC) does not improve survival in pediatric patients with non-acetaminophen acute liver failure","volume":"140","author":"Squires","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N-acetylcysteine in pediatric patients with non-acetaminophen acute liver failure: a placebo-controlled clinical trial","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD012123.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.3748\/wjg.v9.i12.2698","article-title":"N-acetyl cysteine therapy in acute viral hepatitis","volume":"9","author":"Gunduz","year":"2003","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012123.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1319-3767.207711","article-title":"Role of N-acetylcysteine treatment in non-acetaminophen-induced acute live failure: a prospective study","volume":"23","author":"Nabi","year":"2017","journal-title":"Saudi Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Lee WM Stravitz RT Larson AM Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011 Hepatology 2012 55 3 965 7","DOI":"10.1002\/hep.25551"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch7"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1572-0241.2007.01388.x","article-title":"Population-based surveillance for acute liver failure","volume":"102","author":"Bower","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012123.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012123.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003328.pub3","article-title":"Interventions for paracetamol (acetaminophen) overdose","author":"Chiew","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012123.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PEC.0b013e3180308f4b","article-title":"Acute liver failure in children","volume":"23","author":"Cochran","year":"2007","journal-title":"Pediatric Emergency Care"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL clinical practice guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012123.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.gastro.2016.12.026","article-title":"American Gastroenterological Association Institute Guidelines for the diagnosis and management of acute liver failure","volume":"152","author":"Flamm","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cbi.2009.06.003","article-title":"N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes","volume":"181","author":"Gonzalez","year":"2009","journal-title":"Chemico-Biological Interactions"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0020|cit20","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199106273242604","article-title":"Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure","volume":"324","author":"Harrison","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012123.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"Heard","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clinre.2015.01.003","article-title":"Efficacy and safety of acetylcysteine in \"non-acetaminophen\" acute liver failure: a meta-analysis of prospective clinical trials","volume":"39","author":"Hu","year":"2015","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0025|cit25","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/bmj.303.6809.1026","article-title":"Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial","volume":"303","author":"Keays","year":"1991","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"11","key":"10.1002\/14651858.CD012123.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012123.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1097\/MJT.0b013e31829dbc1c","article-title":"Role of N-acetylcysteine to prevent contrast-induced nephropathy: a meta-analysis","volume":"23","author":"Loomba","year":"2016","journal-title":"American Journal of Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD012123.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9128","key":"10.1002\/14651858.CD012123.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pgmj.2004.026005","article-title":"Acute liver failure","volume":"81","author":"O'Grady","year":"2005","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012123.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0035|cit35","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD012123.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"35","key":"10.1002\/14651858.CD012123.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD012123.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012123.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012123.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1345\/aph.1D209","article-title":"Acetylcysteine treatment for non-acetaminophen-induced acute liver failure","volume":"38","author":"Sklar","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD012123.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","article-title":"Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group","volume":"148","author":"Shneider","year":"2006","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012123.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2009.127","article-title":"Management of acute liver failure","volume":"6","author":"Stravitz","year":"2009","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0041-1345(96)00578-7","article-title":"Efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation: an experimental study","volume":"29","author":"Thies","year":"1997","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0046|cit46","doi-asserted-by":"crossref","unstructured":"Thomas J Askie LM Berlin JA Elliott JH Ghersi D Simmonds M Chapter 22: Prospective approaches to accumulating evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch22"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0047|cit47","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA), 2011 ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0048|cit48","first-page":"282","volume-title":"Progress in Liver Diseases","author":"Trey","year":"1970"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0049|cit49","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"2","key":"10.1002\/14651858.CD012123.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.510270520","article-title":"The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure","volume":"27","author":"Walsh","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012123.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012123.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012123.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"7644","key":"10.1002\/14651858.CD012123.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD012123.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012123","article-title":"N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure","author":"Siu","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:29:12Z","timestamp":1697322552000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012123.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012123.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]}}}